Editorial: New products key to Big Pharma recovery

10/1/2007 | Financial Times (free content)

More than reducing work force and implementing other cost-cutting measures, drugmakers should focus on making new products to compensate for financial losses, the Financial Times writes. Companies that opted to purchase smaller firms to secure rights to new drugs have benefited from such deals, but those moves will not solve drugmakers' overall financial problems, the paper says.

View Full Article in:

Financial Times (free content)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR